Alternative data budget confidence hits 3-year high while AI returns remain efficiency-led - Neudata's 2026 industry report

Neudata's 2026 survey found 97% of alternative-data buyers expect spending to rise or remain stable over the next 12 months, up from 89% last year and the strongest reading in the survey's three-year history. Of buyers, 56% reported tangible AI returns, led by efficiency gains (41%), while only 17% cited improved investment performance. Data-quality concerns remain a risk, with 33% reporting deterioration in source quality over the past one to two years, and 39% of failed dataset trials attributed to a lack of discernible signal.

Analysis

This is a modest read-through for public data/analytics vendors rather than a direct earnings catalyst. The relevant mechanism is procurement resilience: recurring data budgets are typically among the last research costs cut, supporting retention and pricing for S&P Global (SPGI), Moody's (MCO), FactSet (FDS), MSCI (MSCI) and LSEG. The near-term revenue benefit is likely strongest for vendors with deeply embedded workflow products and proprietary datasets; generic data distributors face rising commoditization as model-access standards reduce integration friction.

The more important second-order effect is margin polarization. AI appears to be producing operating leverage in research, compliance and data-processing functions before it produces demonstrable alpha, favoring scaled incumbents that can bundle AI functionality into existing contracts while amortizing compute and governance costs. Smaller alternative-data vendors may see trial activity rise but conversion remain difficult, particularly where provenance, refresh rates and exclusivity cannot survive increasingly synthetic information flows.

Over 1-3 months, watch commentary on net retention, seat growth and AI upsell attach rates from FDS, MSCI and SPGI rather than broad AI-spending claims. A sustained improvement in renewal pricing or multi-year contract duration would support multiple expansion; conversely, evidence that AI tools lower end-user seats or enable clients to replace premium terminals with cheaper raw feeds would pressure workflow vendors. Over 6-18 months, data lineage and auditability could become a differentiator as institutional users tighten controls around AI-generated inputs, potentially shifting share toward regulated, curated providers.

Contrarian view: the market may over-credit data vendors for AI demand while underestimating buyer scrutiny of signal quality. If procurement teams increasingly measure dataset ROI, low-differentiation suppliers could face higher churn even in a stable aggregate budget environment. This is insufficient evidence for a standalone trade today because the survey is small, self-selected and not tied to disclosed vendor bookings.

Key Decisions for Investors

• Maintain a watchlist long bias in SPGI and MCO over FDS for the next 1-3 earnings cycles: favor platforms with pricing power, regulatory-grade data and diversified end markets rather than pure seat-based research workflows.
• Use FDS quarterly results as a validation point: consider a tactical long only if organic ASV growth reaccelerates and management identifies measurable AI-related upsell without elevated client attrition; failure to show this would argue for a short FDS versus long SPGI pair.
• Monitor MSCI subscription retention and asset-based fee trends separately from AI commentary. A data-budget tailwind does not offset ETF-flow or AUM sensitivity, so avoid treating this as a clean AI exposure.
• For private-market/data-vendor diligence, prioritize proprietary collection rights, documented lineage and measurable client conversion rates; treat trial volume or MCP/API availability alone as non-monetizable until pricing and renewal data are disclosed.